戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 874086作成日:2026年10月25日

Doxorubicin Hydrochloride → HCID 86598966、化合物

https://huagongshe.com/reaction/874086

反応式

関与物質

役割名称HCID仕込み量
反応物Doxorubicin HydrochlorideHCID 443939—
反応物Ammonium SulfateHCID 6097028—
生成物HCID 86598966HCID 86598966—

反応手順

A preferred non-pegylated liposome of the present invention is loaded with doxorubicin hydrochloride and is prepared using methods described above. In one embodiment, when loading doxorubicin hydrochloride using the active loading procedure described above, the drug is dissolved in a suitable buffer solution (as described above) before loading to get a concentration of at least 25 mM. When the active loading process involves an ammonium sulfate gradient, the ammonium sulfate reacts with doxorubicin hydrochloride to form doxorubicin sulfate. Doxorubicin sulfate is insoluble and remains inside the liposomes after loading. Once any unentrapped or free drug is removed from loaded liposomes, the drug loaded liposomes are diluted using aqueous buffer solution to achieve the required drug concentration. The preferred buffer solution used is sucrose-histidine buffer solution as discussed previously.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08980310B2
出典データセットuspto-grants-2015_03
ORD IDord-896d61cbb7894948b4a509a66e7154cd
出典メモuspto-grants-2015_03